Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3415 | 1989 | 37.5 | 73% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
54 | 3 | ASTHMA//RESPIRATORY SYSTEM//ALLERGY | 90590 |
397 | 2 | ASTHMA//JOURNAL OF ASTHMA//INHALED CORTICOSTEROIDS | 16767 |
3415 | 1 | FORMOTEROL//SALMETEROL//BUDESONIDE FORMOTEROL | 1989 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FORMOTEROL | authKW | 2216348 | 13% | 54% | 266 |
2 | SALMETEROL | authKW | 2026972 | 14% | 49% | 270 |
3 | BUDESONIDE FORMOTEROL | authKW | 423065 | 2% | 66% | 42 |
4 | LONG ACTING BETA AGONISTS | authKW | 344397 | 2% | 46% | 49 |
5 | LEVALBUTEROL | authKW | 313845 | 2% | 66% | 31 |
6 | LONG ACTING BETA2 AGONIST | authKW | 300367 | 3% | 34% | 57 |
7 | BETA2 AGONISTS | authKW | 271264 | 4% | 20% | 89 |
8 | ASTHMA | authKW | 220133 | 32% | 2% | 633 |
9 | INHALED CORTICOSTEROIDS | authKW | 206432 | 7% | 10% | 137 |
10 | FORMOTEROL FUMARATE | authKW | 192190 | 1% | 52% | 24 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Respiratory System | 45377 | 39% | 0% | 781 |
2 | Allergy | 40583 | 21% | 1% | 421 |
3 | Pharmacology & Pharmacy | 3484 | 26% | 0% | 516 |
4 | Critical Care Medicine | 2443 | 7% | 0% | 142 |
5 | Immunology | 1767 | 16% | 0% | 313 |
6 | Medicine, General & Internal | 1594 | 14% | 0% | 286 |
7 | Cardiac & Cardiovascular System | 431 | 7% | 0% | 140 |
8 | Primary Health Care | 166 | 1% | 0% | 20 |
9 | Pediatrics | 98 | 3% | 0% | 69 |
10 | Health Policy & Services | 89 | 1% | 0% | 27 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ABT PNEUMOL IMMUNOL | 30701 | 0% | 100% | 2 |
2 | CLIN DATA MANAGEMENT STAT | 30701 | 0% | 100% | 2 |
3 | PULM ALLERGY ASSOC | 30701 | 0% | 100% | 2 |
4 | BARLICKI UNIV HOSP | 21603 | 1% | 14% | 10 |
5 | ABT PADIATR KARDIOL PNEUMOL ALLERGOL | 20466 | 0% | 67% | 2 |
6 | TEAM PHARMACOEPIDEMIOL PHARMACOECON | 20466 | 0% | 67% | 2 |
7 | CLIN UNIT CHILDHOOD ASTHMA | 19733 | 0% | 43% | 3 |
8 | P MED ALLERGOL | 19346 | 2% | 4% | 30 |
9 | FI TONE P HLTH | 19108 | 1% | 5% | 23 |
10 | ABT HERZTHORAX CHIRURG | 15350 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PULMONARY PHARMACOLOGY & THERAPEUTICS | 66499 | 4% | 5% | 80 |
2 | RESPIRATORY MEDICINE | 55393 | 7% | 3% | 138 |
3 | JOURNAL OF ASTHMA | 20226 | 3% | 2% | 63 |
4 | JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 18104 | 6% | 1% | 112 |
5 | ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 16147 | 3% | 2% | 62 |
6 | ALLERGY AND ASTHMA PROCEEDINGS | 15496 | 2% | 3% | 40 |
7 | EUROPEAN RESPIRATORY JOURNAL | 12438 | 4% | 1% | 86 |
8 | THORAX | 8248 | 3% | 1% | 62 |
9 | AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 6833 | 3% | 1% | 66 |
10 | ALLERGOLOGY INTERNATIONAL | 5047 | 1% | 3% | 10 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FORMOTEROL | 2216348 | 13% | 54% | 266 | Search FORMOTEROL | Search FORMOTEROL |
2 | SALMETEROL | 2026972 | 14% | 49% | 270 | Search SALMETEROL | Search SALMETEROL |
3 | BUDESONIDE FORMOTEROL | 423065 | 2% | 66% | 42 | Search BUDESONIDE+FORMOTEROL | Search BUDESONIDE+FORMOTEROL |
4 | LONG ACTING BETA AGONISTS | 344397 | 2% | 46% | 49 | Search LONG+ACTING+BETA+AGONISTS | Search LONG+ACTING+BETA+AGONISTS |
5 | LEVALBUTEROL | 313845 | 2% | 66% | 31 | Search LEVALBUTEROL | Search LEVALBUTEROL |
6 | LONG ACTING BETA2 AGONIST | 300367 | 3% | 34% | 57 | Search LONG+ACTING+BETA2+AGONIST | Search LONG+ACTING+BETA2+AGONIST |
7 | BETA2 AGONISTS | 271264 | 4% | 20% | 89 | Search BETA2+AGONISTS | Search BETA2+AGONISTS |
8 | ASTHMA | 220133 | 32% | 2% | 633 | Search ASTHMA | Search ASTHMA |
9 | INHALED CORTICOSTEROIDS | 206432 | 7% | 10% | 137 | Search INHALED+CORTICOSTEROIDS | Search INHALED+CORTICOSTEROIDS |
10 | FORMOTEROL FUMARATE | 192190 | 1% | 52% | 24 | Search FORMOTEROL+FUMARATE | Search FORMOTEROL+FUMARATE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DUCHARME, FM , CHROININ, MN , GREENSTONE, I , LASSERSON, TJ , (2010) ADDITION OF LONG-ACTING BETA2-AGONISTS TO INHALED CORTICOSTEROIDS VERSUS SAME DOSE INHALED CORTICOSTEROIDS FOR CHRONIC ASTHMA IN ADULTS AND CHILDREN.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 5. P. - | 193 | 79% | 45 |
2 | DUCHARME, FM , CHROININ, MN , GREENSTONE, I , LASSERSON, TJ , (2010) ADDITION OF LONG-ACTING BETA2-AGONISTS TO INHALED STEROIDS VERSUS HIGHER DOSE INHALED STEROIDS IN ADULTS AND CHILDREN WITH PERSISTENT ASTHMA.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 4. P. - | 197 | 75% | 37 |
3 | WALTERS, EH , GIBSON, PG , LASSERSON, TJ , WALTERS, JAE , (2007) LONG-ACTING BETA2-AGONISTS FOR CHRONIC ASTHMA IN ADULTS AND CHILDREN WHERE BACKGROUND THERAPY CONTAINS VARIED OR NO INHALED CORTICOSTEROID.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 1. P. - | 189 | 83% | 35 |
4 | CHROININ, MN , GREENSTONE, I , LASSERSON, TJ , DUCHARME, FM , (2009) ADDITION OF INHALED LONG-ACTING BETA2-AGONISTS TO INHALED STEROIDS AS FIRST LINE THERAPY FOR PERSISTENT ASTHMA IN STEROID-NAIVE ADULTS AND CHILDREN.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 4. P. - | 187 | 77% | 6 |
5 | NI CHROININ, M , GREENSTONE, IR , DANISH, A , MAGDOLINOS, H , MASSE, V , ZHANG, X , DUCHARME, FM , (2005) LONG-ACTING BETA2-AGONISTS VERSUS PLACEBO IN ADDITION TO INHALED CORTICOSTEROIDS IN CHILDREN AND ADULTS WITH CHRONIC ASTHMA.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 4. P. - | 171 | 80% | 36 |
6 | GREENSTONE, IR , NI CHROININ, MN , MASSE, V , DANISH, A , MAGDALINOS, H , ZHANG, X , DUCHARME, FM , (2005) COMBINATION OF INHALED LONG-ACTING BETA2-AGONISTS AND INHALED STEROIDS VERSUS HIGHER DOSE OF INHALED STEROIDS IN CHILDREN AND ADULTS WITH PERSISTENT ASTHMA.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 4. P. - | 173 | 76% | 54 |
7 | NI CHROININ, M , GREENSTONE, IR , DUCHARME, FM , (2005) ADDITION OF INHALED LONG-ACTING BETA2-AGONISTS TO INHALED STEROIDS AS FIRST LINE THERAPY FOR PERSISTENT ASTHMA IN STEROID-NAIVE ADULTS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 2. P. - | 173 | 77% | 3 |
8 | WALTERS, EH , WALTERS, JAE , GIBSON, MDP , (2003) LONG-ACTING BETA2-AGONISTS FOR STABLE CHRONIC ASTHMA.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 3. P. - | 168 | 81% | 10 |
9 | CHROININ, MN , GREENSTONE, IIG , DUCHARME, F , (2004) ADDITION OF INHALED LONG-ACTING BETA2-AGONISTS TO INHALED STEROIDS AS FIRST LINE THERAPY FOR PERSISTENT ASTHMA IN STEROID NAIVE ADULTS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 4. P. - | 169 | 76% | 2 |
10 | CATES, CJ , CATES, MJ , (2012) REGULAR TREATMENT WITH FORMOTEROL FOR CHRONIC ASTHMA: SERIOUS ADVERSE EVENTS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 4. P. - | 127 | 77% | 5 |
Classes with closest relation at Level 1 |